Enhanced Elimination

Enhanced elimination refers to techniques that increase the removal of an absorbed toxin from the body beyond the patient's intrinsic clearance. Extracorporeal methods—chiefly hemodialysis—are the most prominent, and they are useful only for the minority of poisons whose physicochemical properties allow effective removal.

Definition

Enhanced elimination is the use of interventions—most importantly extracorporeal techniques such as hemodialysis and hemoperfusion—to accelerate the clearance of a systemically absorbed toxin in poisoning.

Scope

The entry explains the rationale for enhanced elimination, the toxin properties (low molecular weight, low protein binding, small volume of distribution, water solubility) that make a poison amenable to extracorporeal removal, and the role of evidence syntheses such as the EXTRIP workgroup recommendations. It is a conceptual reference and does not specify indications, thresholds, or treatment for any individual.

Core questions

• Which physicochemical properties make a toxin removable by extracorporeal techniques?
• How do hemodialysis and related modalities remove a toxin?
• For which poisons is the evidence strongest?
• How does the EXTRIP workgroup grade and standardize recommendations?

Key concepts

• Extracorporeal toxin removal (hemodialysis, hemoperfusion)
• Molecular weight and protein binding
• Volume of distribution
• Water solubility and dialyzability
• EXTRIP workgroup recommendations
• Toxin-specific applicability

Mechanisms

Extracorporeal techniques remove a toxin by passing blood across a semipermeable membrane (hemodialysis) or an adsorbent (hemoperfusion); removal is efficient only when the toxin has a low molecular weight, low plasma-protein binding, a small volume of distribution, and—for dialysis—water solubility, so that an appreciable fraction resides in the plasma and can be cleared. Toxins that are highly protein-bound or widely distributed in tissues are poorly removed. Evidence syntheses by the EXTRIP (Extracorporeal Treatments in Poisoning) workgroup have systematically appraised which poisonings meet these criteria—supporting extracorporeal treatment for some agents while finding it of limited value for others such as tricyclic antidepressants (Gosselin 2014; Calello 2015; Yates 2014; Goldfrank 2019).

Clinical relevance

Enhanced elimination connects the pharmacokinetics of a toxin to the feasibility of removing it, and it is relevant to a small set of severe poisonings. The entry frames the concept and its determinants for reference and does not state indications, thresholds, or treatment decisions for any patient.

History

Extracorporeal removal of poisons has been used since the mid-twentieth century, but its application was long heterogeneous; the EXTRIP collaboration, formed in the 2010s, brought systematic-review methodology to the question and produced toxin-specific recommendations that standardized when extracorporeal treatment is supported by evidence (Gosselin 2014; Calello 2015).

Debates

Which poisonings genuinely benefit from extracorporeal removal?

Because only toxins with favorable physicochemical properties are efficiently removed, the EXTRIP syntheses support extracorporeal treatment for some agents (for example, certain metformin-associated states) while concluding it is of limited value for others such as tricyclic antidepressants, underscoring that the technique is not broadly applicable.

Key figures

• Marc Ghannoum
• Robert Hoffman
• Sophie Gosselin

Seminal works

• gosselin-2014
• calello-2015

Frequently asked questions

What makes a poison removable by hemodialysis?

A toxin is amenable to hemodialysis when it has a low molecular weight, low protein binding, a small volume of distribution, and water solubility, so that enough of it circulates in the plasma to be cleared. Highly protein-bound or tissue-distributed toxins are poorly removed.

What is the EXTRIP workgroup?

EXTRIP (Extracorporeal Treatments in Poisoning) is an international collaboration that uses systematic-review methods to produce toxin-specific recommendations on whether extracorporeal treatment is supported by evidence. This entry references its role for orientation, not as treatment guidance.